CaliberCos heads into the aftermath of its Q1 2026 report with short interest at a five-week high, a meaningful earnings miss already on the tape, and a guidance affirmation that lands well below Street estimates.
The week's defining move was in short positioning. Estimated short interest exploded more than 350% over the past seven days, reaching 4.3% of the free float — a level not seen since mid-April. The build was aggressive and compressed: shares short climbed from roughly 54,000 on May 4 to 243,000 by May 12, all in advance of Tuesday evening's earnings release. That kind of front-running is notable for a name this small. The ORTEX short score confirmed the shift, jumping from 34.4 on May 4 to a peak of 60.1 on May 5 before settling back to 43.3 by May 12 — still well above where it started the month.
The borrow market tells a more measured story, though not a comfortable one. Cost to borrow has crept up roughly 8% over the past month to around 12.9% annualised. That is elevated for a micro-cap asset manager but down from the 18.6% peak touched in early April. Availability remains loose — lending pool availability is ample relative to current short interest, with the borrow demand only partially absorbing what is on offer. That limits immediate squeeze pressure, even with the short count having more than tripled in a week.
The earnings print that arrived Tuesday evening provided clear vindication for the bears. Q1 revenue came in at $4.3 million, missing the $6.2 million estimate by roughly 30%. EPS of -$0.52 missed the $0.06 consensus by a wide margin. Management then affirmed full-year 2026 sales guidance of $18–22 million against a Street estimate of $26.6 million — a guidance range that lands some 15–30% below what analysts had modelled. The pattern is consistent with prior quarters: when Caliber reported Q4 2025 results in March, the stock fell 5.6% the next day and 20.8% over the following five sessions. The Q4 print itself showed revenue halved year-on-year to $4.1 million.
On valuation, the analyst price target of $6.00 on file is stale — last updated in November 2025 when the stock was trading at a materially different level. At the current price of $0.99, that target is too far from the current tape to carry meaningful weight, and should be treated as dated. The factor scores offer limited comfort: the EPS surprise rank of 97th percentile is a paradox — it reflects the consistency of the company's history of missing, not beating, estimates. The dividend score of 28 and short score rank of 31 round out a picture of a stock where few signals are pointing constructively.
Institutional ownership is thin and concentrated. Three individuals — Jennifer Schrader, John Loeffler, and Roy Bade — account for the top three holder positions, together holding close to 8% of shares. Vanguard built a fresh stake of 35,224 shares in Q1 2026, and Geode added 26,200 shares in February — passive index-rebalancing rather than active conviction. The most recent insider activity on record is a CFO sale of 28,500 shares in April 2025, now over a year old and outside the window of useful inference.
The immediate question for traders is how the stock opens tomorrow with both an EPS miss and a guidance range that trails consensus by double digits now fully in the market. The next scheduled corporate event is the Planet MicroCap conference in Las Vegas on June 16–17 — a venue where management will face direct investor questions about the path to closing the gap between the $18–22 million guidance range and the $26.6 million estimate it has replaced.
See the live data behind this article on ORTEX.
Open CWD on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
